Loading...
XSWX
SFZN
Market cap3.91bUSD
Dec 05, Last price  
71.80CHF
1D
-0.42%
1Q
-15.53%
Jan 2017
-66.29%
Name

Siegfried Holding AG

Chart & Performance

D1W1MN
XSWX:SFZN chart
P/E
19.63
P/S
2.43
EPS
3.66
Div Yield, %
5.01%
Shrs. gr., 5y
59.21%
Rev. gr., 5y
9.21%
Revenues
1.29b
+1.82%
318,335,000299,766,000318,256,000288,745,000283,041,000314,409,000328,095,000367,800,000374,940,000315,282,000480,571,000717,729,000750,468,000794,297,000833,514,000845,062,0001,102,423,0001,229,518,0001,271,494,0001,294,573,000
Net income
160m
+41.93%
36,534,00032,392,00049,710,000-74,834,000-35,263,000-16,243,0009,599,00020,868,00053,851,00038,556,00039,100,00027,906,00039,732,00056,310,00053,147,00060,867,00095,600,000156,490,000112,774,000160,064,000
CFO
169m
-19.09%
47,953,00052,142,00062,657,00022,294,00045,465,00057,677,00031,810,00054,322,00067,529,00024,642,00023,075,00057,113,00084,632,000106,001,00055,858,000105,284,000112,357,000134,505,000208,608,000168,777,000
Dividend
May 03, 20243.6 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
IPO date
Jan 01, 1973
Employees
3,633
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT